Frontiers in Cellular and Infection Microbiology (Jan 2021)

Heterogeneous Klebsiella pneumoniae Co-infections Complicate Personalized Bacteriophage Therapy

  • Jinhong Qin,
  • Jinhong Qin,
  • Jinhong Qin,
  • Nannan Wu,
  • Juan Bao,
  • Xin Shi,
  • Hongyu Ou,
  • Shanke Ye,
  • Wei Zhao,
  • Zhenquan Wei,
  • Jinfeng Cai,
  • Lisha Li,
  • Mingquan Guo,
  • Mingquan Guo,
  • Jingyan Weng,
  • Hongzhou Lu,
  • Demeng Tan,
  • Jianzhong Zhang,
  • Qin Huang,
  • Zhaoqin Zhu,
  • Yejing Shi,
  • Chunlan Hu,
  • Xiaokui Guo,
  • Xiaokui Guo,
  • Tongyu Zhu,
  • Tongyu Zhu,
  • Tongyu Zhu

DOI
https://doi.org/10.3389/fcimb.2020.608402
Journal volume & issue
Vol. 10

Abstract

Read online

Multidrug-resistant (MDR) organisms have increased worldwide, posing a major challenge for the clinical management of infection. Bacteriophage is expected as potential effective therapeutic agents for difficult-to-treat infections. When performing bacteriophage therapy, the susceptibility of lytic bacteriophage to the target bacteria is selected by laboratory isolate from patients. The presence of a subpopulation in a main population of tested cells, coupled with the rapid development of phage-resistant populations, will make bacteriophage therapy ineffective. We aimed to treat a man with multifocal urinary tract infections of MDR Klebsiella pneumoniae by phage therapy. However, the presence of polyclonal co-infectious cells in his renal pelvis and bladder led to the failure of three consecutive phage therapies. After analysis, the patient was performed with percutaneous nephrostomy (PCN). A cocktail of bacteriophages was selected for activity against all 21 heterogeneous isolates and irrigated simultaneously via the kidney and bladder to eradicate multifocal colonization, combined with antibiotic treatment. Finally, the patient recovered with an obviously improved bladder. The success of this case provides valuable treatment ideas and solutions for phage treatment of complex infections.Clinical Trial Registrationwww.chictr.org.cn, identifier ChiCTR1900020989.

Keywords